NKF — Immunohistochemistry Antibody Assay, C-Kit Class III

FDA Device Classification

FDA product code NKF covers "Immunohistochemistry Antibody Assay, C-Kit", a Class III medical device regulated under 21 CFR 864.1860. Submissions are reviewed by the Hematology panel.

Classification Details

Product Code
NKF
Device Class
Class III
Regulation Number
864.1860
Submission Type
Review Panel
PA
Medical Specialty
Hematology
Implant
No

Definition

Identification/Intended Use - The anti-c-KIT primary antibody is intended for laboratory use, via light microscopy, for the qualitative detection of KIT protein in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors (GISTs) using either an automated immunohistochemistry staining system or manual assay. It is indicated as an aid in the selection of GIST patients who may qualify for imatinib mesylate therapy within the context of the patient's clinical history, tumor morphology, and other diagnostic tests evaluated by a qualified pathologist. The test is not intended as the sole basis for making the diagnosis of GIST and is not intended as the sole basis for selecting imatinib mesylate therapy. A negative result would not necessarily exclude the diagnosis of GIST